Αρχική World News EMA Recommends Granting a Marketing Authorisation for Nirogacestat World News EMA Recommends Granting a Marketing Authorisation for Nirogacestat Από Ogkologos - 3 Ιουλίου, 2025 407 0 Facebook Twitter Google+ Pinterest WhatsApp It is intended for the treatment of adult patients with progressing desmoid tumours Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Ahead of the Special European Council Meeting on 26-27 November, ESMO Calls on EU Governments to Continue Support for the Cancer Mission European Parliament backs key priorities advocated by ESMO for cancer research and innovation FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer MOST POPULAR Returning to Dental Care 24 Αυγούστου, 2020 Financial Navigation Can Reduce the Financial Toxicity of Cancer Care 21 Απριλίου, 2023 ΙΣΤΟΡΙΑ 18 Ιανουαρίου, 2019 Mom Diagnosed With Breast Cancer Adopts Healthy Lifestyle To Reinvent Her... 7 Νοεμβρίου, 2021 Φόρτωση περισσοτέρων HOT NEWS New on NCI Websites for June 2018 FX-909 Demonstrates Acceptable Safety and Preliminary Antitumour Activity, Establishing a Proof... Talquetamab Continues To Demonstrate High Overall Response Rates in Heavily Pretreated... Breast Cancer Survivor Given 12 Months to Live After Left Side...